A new study at the University of Missouri found that while oxygen treatment reduced cell activity, it did not lead to any significant improvements in metabolic function for patients with type 2 diabetes.
Jacqueline Limberg, the study's lead author, explained that previous excitement over research focused on rat models suggested removing overactive chemoreceptors could enhance health, prompting investigation into oxygen's influence on these cells.
The research specifically looked at the activity of peripheral chemoreceptors in adults with type 2 diabetes, confirming their overactivity correlates with higher blood sugar levels, but hyperoxia didn't improve outcomes.
Despite initial hypotheses, the study concluded that manipulating oxygen levels in this way did not yield beneficial effects on metabolic function, challenging prior expectations regarding chemoreceptor activity.
Collection
[
|
...
]